{"id":267,"date":"2010-05-01T00:24:38","date_gmt":"2010-04-30T13:24:38","guid":{"rendered":"http:\/\/www.brainsmatter.com\/?p=267"},"modified":"2012-08-05T11:00:02","modified_gmt":"2012-08-05T11:00:02","slug":"114-corin-storkey-beauty-and-the-type-2-diabetes-synthetic-chemist-geek","status":"publish","type":"post","link":"https:\/\/www.brainsmatter.com\/?p=267","title":{"rendered":"114 &#8211; Corin Storkey &#8211; Beauty and the Type 2 Diabetes Synthetic Chemist Geek"},"content":{"rendered":"<p>In this episode, I talk to Corin Storkey, from the Bio21 Institute at the University of Melbourne.  Corin is a synthetic organic chemist, and spoke to me about some of the research he was doing in synthesising compounds that may one day be used as pharmaceuticals to treat patients suffering from Type 2 Diabetes.<\/p>\n<p>We talked about:<\/p>\n<p>&#8211; Life as a PhD student<br \/>\n&#8211; What type 2 diabetes is<br \/>\n&#8211; Some of the causes of diabetes<br \/>\n&#8211; The effects of type 2 diabetes<br \/>\n&#8211; Glycoside inhibitors, and how these were used in this research<br \/>\n&#8211; Finding the compounds used in traditional medicines (eg Ayurveda) and isolating these to use in modern drug research<br \/>\n&#8211; How do these compounds help with Type 2 diabetes?<br \/>\n&#8211; What are the shortcomings?<br \/>\n&#8211; What can people do to help them deal with Type 2 diabetes?<\/p>\n<p>Today&#8217;s listener of the episode is Olga Bourlin from the US<\/p>\n<p><img decoding=\"async\" src=\"http:\/\/i182.photobucket.com\/albums\/x287\/brainsmatter\/audio.jpg\"><a href=\"http:\/\/predictabledata.com\/projects\/brainsmatter\/BM114-Type2Diabetes.mp3\">Download MP3 of Ep 114<\/a><\/p>\n<p>Please vote for this podcast this month at<br \/>\n<a href=\"http:\/\/www.podcastalley.com\/one_vote2.php?pod_id=40939\" title=\"Podcast Alley - Your Podcast Library\"><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/www.podcastalley.com\/images\/podcastalley_icon.gif\" alt=\"PodcastAlley.com Feeds\" border=\"0\" height=\"15\" width=\"80\" \/><\/a><\/p>\n<p><a href=\"https:\/\/www.paypal.com\/cgi-bin\/webscr?cmd=_xclick&amp;business=brainsmatterinbox%40gmail%2ecom&amp;no_shipping=2&amp;no_note=1&amp;tax=0&amp;currency_code=USD&amp;bn=PP%2dDonationsBF&amp;charset=UTF%2d8\"><img decoding=\"async\" src=\"https:\/\/www.paypal.com\/en_US\/i\/btn\/x-click-but04.gif\" alt=\"Donate via Paypal\" \/><\/a><\/p>\n<p>You can donate by clicking on the button above, and subscribe by <a href=\"http:\/\/phobos.apple.com\/WebObjects\/MZStore.woa\/wa\/viewPodcast?id=257301606\">subscribing in iTunes <img decoding=\"async\" src=\"http:\/\/i182.photobucket.com\/albums\/x287\/brainsmatter\/iTunesWord.jpg\"><\/a><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/i.creativecommons.org\/l\/by-nc-nd\/2.5\/au\/88x31.png\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In this episode, I talk to Corin Storkey, from the Bio21 Institute at the University of Melbourne. Corin is a synthetic organic chemist, and spoke to me about some of the research he was doing in synthesising compounds that may one day be used as pharmaceuticals to treat patients suffering from Type 2 Diabetes. We [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,16,20],"tags":[51,52,356,76,183,194,256],"class_list":["post-267","post","type-post","status-publish","format-standard","hentry","category-chemistry","category-interview","category-podcast","tag-beauty-and-the-geek","tag-beauty-and-the-geek-australia","tag-chemistry","tag-corin-storkey","tag-organic-chemistry","tag-pharmaceuticals","tag-synthetic-chemistry"],"_links":{"self":[{"href":"https:\/\/www.brainsmatter.com\/index.php?rest_route=\/wp\/v2\/posts\/267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.brainsmatter.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.brainsmatter.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.brainsmatter.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.brainsmatter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=267"}],"version-history":[{"count":3,"href":"https:\/\/www.brainsmatter.com\/index.php?rest_route=\/wp\/v2\/posts\/267\/revisions"}],"predecessor-version":[{"id":657,"href":"https:\/\/www.brainsmatter.com\/index.php?rest_route=\/wp\/v2\/posts\/267\/revisions\/657"}],"wp:attachment":[{"href":"https:\/\/www.brainsmatter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.brainsmatter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.brainsmatter.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}